Considering the significant role of the CCR2 receptor in cancer, in this study, for the first time, we studied the effect of this compound in preventing the development of CRC in mouse models and cell lines through inhibition of the CCR2_CCL2 signaling pathway. The gene discussed is CCR2; the disease is colorectal carcinoma.